Safety and performance assessment of hyaluronic acid-based vitreous substitutes in patients with phthisis bulbi.

Andre SchulzPhilip WakiliKai JanuschowskiWerner R HeinzMelanie EngelhardHelge MenzPeter Szurman

Published in: Acta ophthalmologica (2023)

Hyaluronic acid-based hydrogels are biocompatible vitreous substitutes in humans and can increase and stabilize IOP in patients with phthisis bulbi for about 3 months.

Keyphrases

hyaluronic acid
drug release
ionic liquid
drug delivery